nonvalvular atrial fibrillation
Nonvalvular Atrial Fibrillation and Stroke: A Review
... in Atrial Fibrillation (SPAF) 15 , 1330 patients were followed for a mean period of ...with nonvalvular atrial ...for Atrial Fibrillation (BAATAF) 16 the efficacy of low dose ...
5
Clinical utility of rivaroxaban in stroke prevention associated with nonvalvular atrial fibrillation – patient considerations
... for nonvalvular atrial fibrillation recommends a 15 mg daily dose in patients with moderate impairment of renal function ( creatinine clearance 30–49 mL per ...with nonvalvular atrial ...
6
Factors Associated with Ischemic Stroke on Therapeutic Anticoagulation in Patients with Nonvalvular Atrial Fibrillation
... 8. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembo- lism in atrial fibrillation using a novel risk factor-based approach: the ...
8
Nonvalvular atrial fibrillation: a study of epidemiology, demography and clinicoetiological profile in Central India
... of nonvalvular atrial fibrillation were enrolled prospectively in the study during the period February 2017 to May ...of atrial fibrillation, either chronic or paroxysmal were enrolled ...
7
An evidence-based review of edoxaban and its role in stroke prevention in patients with nonvalvular atrial fibrillation
... Abstract: Atrial fibrillation is the most common arrhythmia in the ...result, atrial fibrillation patients are risk-stratified using the CHADS 2 or CHA 2 DS 2 -VASc scoring ...with ...
11
Patient satisfaction after switching from warfarin to apixaban in patients with nonvalvular atrial fibrillation: AGAIN study
... methods: Nonvalvular atrial fibrillation (NVAF) patients who were scheduled to switch anticoagulants from warfarin to apixaban were enrolled and treated with apixaban for 12 ...
10
The value of diastolic function parameters in the prediction of left atrial appendage thrombus in patients with nonvalvular atrial fibrillation
... with nonvalvular AF who underwent a TEE to “rule-out” left atrial appendage thrombus be- tween January 1, 2005 and December 31, ...with atrial flutter, without intervening episodes of atrial ...
9
Clinical Characteristics and Impact of Diabetes Mellitus on Outcomes in Patients with Nonvalvular Atrial Fibrillation
... There are some limitations in our study that should be not- ed. First, hemoglobin A1c percentages and fasting blood sug- ars were not recorded, limiting insight into glucose control, a factor that may have an effect on ...
10
The use status of anticoagulation drugs for inpatients with nonvalvular atrial fibrillation in Southwest China
... After our comprehensive study of hospitalized AF patients in Southwest China, we demonstrated that NVAF inpatients received a lower level of anticoagulation drugs for stroke preventio[r] ...
9
Motion of left atrial appendage as a determinant of thrombus formation in patients with a low CHADS2 score receiving warfarin for persistent nonvalvular atrial fibrillation
... As for ultrasound parameters, spontaneous echo con- trast (SEC) and LAA peak emptying flow velocity (LAAPV) have been proposed as echocardiographic pre- dictors of LAA thrombus [7,8]. However, the optimal cutoff values ...
8
Setting priorities in the health care sector – the case of oral anticoagulants in nonvalvular atrial fibrillation in Denmark
... Methods: In a cost analysis, the annual average total costs of five oral anticoagulants (warfarin and non-vitamin K oral anticoagulants [NOACs; dabigatran, rivaroxaban, apixaban, and ed[r] ...
11
A comparison of dabigatran and warfarin for stroke prevention in elderly Asian population with nonvalvular atrial fibrillation: An audit of current practice in Malaysia
... This is a single-centre retrospective cohort study at Malaysia’s National Heart Institute. The research ethics committee of the National Heart Institute approved the study protocol and informed consent was waived for a ...
5
Direct oral anticoagulants: key considerations for use to prevent stroke in patients with nonvalvular atrial fibrillation
... Abstract: Atrial fibrillation (AF) is the most common cardiac arrhythmia ...with nonvalvular AF, particularly in special patient populations (eg, those with renal impairment) and other specific ...
16
Cost-effectiveness of edoxaban versus rivaroxaban for stroke prevention in patients with nonvalvular atrial fibrillation (NVAF) in the US
... Objective: To evaluate the relative cost-effectiveness of two once-daily regimens of novel oral anticoagulation therapy – edoxaban (60 mg/30 mg dose-reduced) versus [r] ...
12
Impact of B-type natriuretic peptide level on the risk of left atrial appendage thrombus in patients with nonvalvular atrial fibrillation: a prospective study
... TEE. Atrial fibrillation chronicity was classified as: 1) paroxysmal, defined as spontaneously reverting to sinus rhythm within 7 days; 2) persistent, de- fined as lasting more than 7 days but less than 12 ...
7
Novel Therapeutic Options for the Treatment of Nonvalvular Atrial Fibrillation
... 14,264 nonvalvular atrial fibrilla- tion patients with moderate-to-high risk for ...included atrial fibrillation pa- tients with average age 73 years, mean CHADS2 score of ...
8
Clinical utility of apixaban in the prevention and treatment of venous thromboembolism: current evidence
... Apixaban has shown noninferiority to warfarin in the setting of stroke prevention in nonvalvular atrial fibrillation and has been studied for the prevention and treatment of VTE. Apixaban does not ...
11
Download Download PDF
... Once-daily dosing of non-vitamin K antagonist oral anticoagulants (NOACs) may increase patient adherence to treatment but may also be associ- ated with a higher risk of bleeding. In this study, we investigated the ...
6
Quick reference guide to apixaban
... with nonvalvular atrial fibrillation in the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for preven- tion of stroke and embolism trial in atrial ...
5
Ximelagatran: direct thrombin inhibitor
... with nonvalvular atrial fibrillation, noninferior to standard therapy as acute and extended therapy of deep vein thrombosis (DVT), and superior to warfarin for the prevention of venous ...
10